Evelo Biosciences, Inc.
EVLODelisted Dec 27, 2023- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001694665
Evelo Biosciences, Inc. was delisted on Dec 27, 2023; its insiders filed their last Form 4 on Nov 8, 2023; 29 institutions reported holding it in 13F filings for Q3 2023, worth $52.0M in total; no superinvestor held it.
13F holders, Q2 2023
Institutional positions in Evelo Biosciences, Inc. as of Jun 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 25
- −14 vs. Q1 2023
- Shares held
- 3.60M
- −683.8K (−16.0%) vs. Q1 2023Converted for a 1-for-20 split
- Total value
- $11.3M
- −$4.19M (−27.0%) vs. Q1 2023
- New holders
- 1
- 7 more added
- Sold out
- 15
- 11 more reduced
Compare with Q1 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting EVLO on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 0 | $0 |
| Q3 2024 | 0 | $0 |
| Q2 2024 | 0 | $0 |
| Q1 2024 | 0 | $0 |
| Q4 2023 | 2 | $2.63K |
| Q3 2023 | 29 | $52.0M |
| Q2 2023 | 25 | $11.3M |
| Q1 2023 | 39 | $15.5M |
| Q4 2022 | 44 | $140.1M |
| Q3 2022 | 41 | $180.0M |
| Q2 2022 | 46 | $180.4M |
| Q1 2022 | 68 | $161.1M |
| Q4 2021 | 66 | $290.1M |
| Q3 2021 | 64 | $331.6M |
| Q2 2021 | 66 | $645.4M |
| Q1 2021 | 62 | $508.0M |
Institutions, Q2 2023
Shares, value and share of portfolio for each institution holding Evelo Biosciences, Inc.; share changes are against Q1 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Flagship Pioneering Inc. | 2,521,369 | $8.19M | 0.37% | 00.0% | UnchangedConverted for a 1-for-20 split |
| State of Michigan Retirement System | 203,536 | $661.5K | 0.00% | 00.0% | UnchangedConverted for a 1-for-20 split |
| Vanguard Group Inc | 155,896 | $506.7K | 0.00% | −2,523−1.6% | ReducedConverted for a 1-for-20 split |
| HarbourVest Partners LLC | 153,175 | $497.8K | 0.14% | 00.0% | UnchangedConverted for a 1-for-20 split |
| FMR LLC | 126,425 | $410.9K | 0.00% | −683,429−84.4% | ReducedConverted for a 1-for-20 split |
| Barclays PLC | 93,193 | $302.9K | 0.00% | +92,649+17,026.3% | AddedConverted for a 1-for-20 split |
| Credit Suisse AG | 180,520 | $180.5K | 0.00% | 00.0% | UnchangedConverted for a 1-for-20 split |
| BlackRock Inc. | 53,539 | $174.0K | 0.00% | −4,231−7.3% | ReducedConverted for a 1-for-20 split |
| Alphabet Inc. | 53,024 | $172.3K | 0.01% | 00.0% | UnchangedConverted for a 1-for-20 split |
| Geode Capital Management, LLC | 29,072 | $94.5K | 0.00% | −1,362−4.5% | ReducedConverted for a 1-for-20 split |
| Mayo Clinic | 22,577 | $73.4K | 0.08% | −1,385−5.8% | ReducedConverted for a 1-for-20 split |
| Morgan Stanley | 5,706 | $18.5K | 0.00% | +2,775+94.7% | AddedConverted for a 1-for-20 split |
| Tower Research Capital LLC (TRC) | 3,318 | $10.8K | 0.00% | +1,702+105.3% | AddedConverted for a 1-for-20 split |
| Group One Trading, L.P. | 1,018 | $3.31K | 0.00% | +1,018 | New |
| UBS Group AG | 260 | $845 | 0.00% | −140−34.9% | ReducedConverted for a 1-for-20 split |
| JPMorgan Chase & Co | 200 | $650 | 0.00% | +4+1.9% | AddedConverted for a 1-for-20 split |
| Citigroup Inc | 95 | $309 | 0.00% | +33+52.1% | AddedConverted for a 1-for-20 split |
| Advisor Group Holdings, Inc. | 75 | $242 | 0.00% | 00.0% | UnchangedConverted for a 1-for-20 split |
| China Universal Asset Management Co., Ltd. | 72 | $234 | 0.00% | −2−3.1% | ReducedConverted for a 1-for-20 split |
| Larson Financial Group LLC | 36 | $117 | 0.00% | −1−2.6% | ReducedConverted for a 1-for-20 split |
| Wells Fargo & Company | 21 | $68 | 0.00% | +1+4.5% | AddedConverted for a 1-for-20 split |
| Bank of America Corp | 15 | $49 | 0.00% | −2,526−99.4% | ReducedConverted for a 1-for-20 split |
| Royal Bank of Canada | 134 | $0 | 0.00% | +133+19,042.9% | AddedConverted for a 1-for-20 split |
| Daiwa Securities Group Inc. | 7 | $0 | 0.00% | −1−10.3% | ReducedConverted for a 1-for-20 split |
| Simplex Trading, LLC | 8 | $0 | 0.00% | −65−89.1% | ReducedConverted for a 1-for-20 split |
| CVI Holdings, LLC | 0 | $0 | 0.00% | −42,029−100.0% | Sold outConverted for a 1-for-20 split |
| Susquehanna International Group, LLP | 0 | $0 | 0.00% | −9,205−100.0% | Sold outConverted for a 1-for-20 split |
| State Street Corp | 0 | $0 | 0.00% | −7,606−100.0% | Sold outConverted for a 1-for-20 split |
| Trustees of Columbia University in the City of New York | 0 | $0 | 0.00% | −5,693−100.0% | Sold outConverted for a 1-for-20 split |
| Bridgeway Capital Management, LLC | 0 | $0 | 0.00% | −5,265−100.0% | Sold outConverted for a 1-for-20 split |
| Northern Trust Corp | 0 | $0 | 0.00% | −4,717−100.0% | Sold outConverted for a 1-for-20 split |
| Jefferies Financial Group Inc. | 0 | $0 | 0.00% | −3,750−100.0% | Sold outConverted for a 1-for-20 split |
| Millennium Management LLC | 0 | $0 | 0.00% | −2,921−100.0% | Sold outConverted for a 1-for-20 split |
| Goldman Sachs Group Inc | 0 | $0 | 0.00% | −1,285−100.0% | Sold outConverted for a 1-for-20 split |
| Virtu Financial LLC | 0 | $0 | 0.00% | −1,217−100.0% | Sold outConverted for a 1-for-20 split |
| Avantax Planning Partners, Inc. | 0 | $0 | 0.00% | −750−100.0% | Sold outConverted for a 1-for-20 split |
| Bank of New York Mellon Corp | 0 | $0 | 0.00% | −658−100.0% | Sold outConverted for a 1-for-20 split |
| Affinity Capital Advisors, LLC | 0 | $0 | 0.00% | −530−100.0% | Sold outConverted for a 1-for-20 split |
| BNP Paribas Arbitrage, SA | 0 | $0 | 0.00% | −83−100.0% | Sold outConverted for a 1-for-20 split |
| National Bank of Canada | 0 | $0 | 0.00% | −5−100.0% | Sold outConverted for a 1-for-20 split |